Myths that must be overcome to ensure successful commercialisation of biosimilars
10 October 2016 | By SMi Group
SMi's 3rd annual Biosimilars North America conference will be returning to Iselin, New Jersey, USA in November 2016...
List view / Grid view
News
Pancreatic cancer paves the path for metastases in the liver at an exceptionally early stage
10 October 2016 | By Niamh Louise Marriott, Digital Content Producer
Pancreatic cancer is an exceptionally aggressive type. Frequently, metastases already start to grow in other organs, particularly often in the liver...
How breast cancer screening could be better and less painful
10 October 2016 | By Niamh Louise Marriott, Digital Content Producer
Flexible plates therefore enable better image quality without increased compression force. One can also reduce the compression force and the pain...
UK biotech Orchard Therapeutics opens US operations in California
6 October 2016 | By Niamh Louise Marriott, Digital Content Producer
Foster City will serve as headquarters for Orchard Therapeutics North America, and will provide the central base for laboratory operations associated...
Asceneuron receives Parkinson’s research grant from the Michael J. Fox Foundation
6 October 2016 | By Niamh Louise Marriott, Digital Content Producer
The grant from the MJFF therapeutic pipeline program will support studies for the optimisation of molecules to provide preclinical proof of concept in...
Epigenetics provides new insights into the pathogenesis of lymphoma
5 October 2016 | By Niamh Louise Marriott, Digital Content Producer
Epigenetics looks at special regulation mechanisms, such as DNA methylation and histone modifications, which determine the gene expression pattern...
Brain diseases manifest in the retina of the eye
5 October 2016 | By Niamh Louise Marriott, Digital Content Producer
Dr Henri Leinonen investigated functional abnormalities of the retina using mouse models of human central nervous system diseases...
Lifestyle vs bad luck? New stem cell evidence provides insight to what causes cancer
5 October 2016 | By Niamh Louise Marriott, Digital Content Producer
DNA code of stem cells acquires errors at a constant rate, even with differing cancer incidence, providing insight to the bad luck vs lifestyle debate...
EBV-derived microRNAs silence immune alarm signals of the host cell
5 October 2016 | By Niamh Louise Marriott, Digital Content Producer
The virus drives production of small molecules, so-called microRNAs, which suppress alarm signals sent out by the infected cell...
Healx secures £1.5m from Amadeus Capital to combat rare diseases by ‘repurposing’ drugs
4 October 2016 | By Niamh Louise Marriott, Digital Content Producer
Amadeus Capital Partners has made an early-stage investment in Healx that seeks new uses for existing drugs in the fight against rare diseases...
Researchers identify a key molecule in psoriasis development
4 October 2016 | By Niamh Louise Marriott, Digital Content Producer
To go further in the TREX2 role in homeostasis and skin pathogenesis, the researchers wanted to see the role of this nuclease on psoriasis...
Hebrew University researchers design peptides that block bacterial superantigen toxins
4 October 2016 | By Niamh Louise Marriott, Digital Content Producer
The ability of staphylococcal and streptococcal bacteria to cause disease is due to numerous virulence factors, in which the superantigen plays a role...
ReViral appoints new CEO
3 October 2016 | By Niamh Louise Marriott, Digital Content Producer
Eddy Littler said, “I am pleased to be joining at this critical time where I can help move the lead programme RV521 forward into clinical development...
IL-34: a new target to tackle chemo-resistant cancer cells
3 October 2016 | By Niamh Louise Marriott, Digital Content Producer
Researchers found that A549-DR was resistant to the chemotherapeutic drug when transplanted in mice, while A549-DR with depleted IL-34 became sensitive...
Active Motif and Swift Biosciences partner to develop advancements in epigenetics
3 October 2016 | By Niamh Louise Marriott, Digital Content Producer
Epigenetics-based research tools company Active Motif has entered into adevelopment partnership with Swift Biosciences, a next generation sequencing...